Medical Science Liaison, France

Blueprint Medicines

2 months ago

4.6 on Glassdoor

Lille, France

Hybrid

Full Time

Manager

0 applicants

View Job Listing

Apply to 100+ jobs

About this role

The Medical Science Liaison (MSL) is a field-based scientific and clinical expert representing Blueprint Medicines in Northern France who supports the company’s mission to advance precision therapies in allergy/inflammation and oncology/hematology. The role serves as a scientific bridge between external clinical communities and internal teams, ensuring scientific and clinical knowledge is communicated effectively while aligning with company values and standards. This position reports to the Country Medical Lead and is part of the company’s medical organization.

Skills

Qualifications

PhDMDPharmDMSc

About Blueprint Medicines

blueprintmedicines.com

Blueprint Medicines is a biotechnology company focused on developing targeted therapies for patients with cancer and rare diseases. The company uses precision medicine and genomics to design drugs that selectively inhibit disease-causing proteins, particularly kinase-driven cancers and systemic mastocytosis.

Recent company news

MSN

Sanofi To Buy Blueprint Medicines For Up To $9.5B: Retail Sees More Acquisition Offers From European Pharma Companies

4 days ago

Yahoo Finance

Blueprint Medicines, a Sanofi Company, Announces Four-Year PIONEER Data Showing Sustained Benefit and Long-Term Safety of AYVAKIT® (avapritinib) in Indolent Systemic Mastocytosis

2 weeks ago

European Pharmaceutical Review

Blueprint’s rare disease drug Ayvakit shows long-term benefit

1 week ago

Investopedia

Blueprint Medicines Stock Soars as Biotech Agrees to Over $9B Sanofi Takeover

Jun 2, 2025

PR Newswire

Blueprint Medicines, a Sanofi Company, Highlights Long-Term Clinical Benefit of AYVAKIT® (avapritinib) Across Indolent and Advanced Systemic Mastocytosis at 2025 ASH Annual Meeting

Dec 5, 2025